Shree Ganesh Bio-Tech (India) Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Shree Ganesh Bio-Tech (India) Ltd. on BSE

Load latest

Shree Ganesh Bio-Tech (India) Ltd.

30 Oct 2020

Result

Shree Ganesh Biotech (India) Ltd - 539470 - Submission Of Half Yearly Disclosure On Related Party …

BSE India

In compliance with Regulation 23(9) of SEBI (Listing Obligation and Disclosure Requirements) (Amendments) Regulations. 2018, please find attached herewith disclosure on Related Party Transactions, on consolidated basis in the format specified in accordance with applicable accounting standards for the half year ended on September 30, 2020. Please acknowledge and take the same on your record.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

30 Oct 2020

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation …

BSE India

Pursuant to SEBI Circular - CIR/CFD/CMD1/162/2019 dated 24th December, 2019 regarding statement on Deviation or variation for proceeds of public issue/Rights Issue/preferential issue, Qualified institutional placement (QIP) etc., read with Regulation 32(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we would like to inform that: The Company does not have any funds remaining unutilised as on 30th September 2020, or as on date, out of the proceeds of public issue/Rights Issue/preferential issue, qualified institutional placement (QIP) etc., if any undertaken by it at anytime in the past. In view of the aforesaid, no information is being provided by way of Annexure-A pursuant to the said Regulation / Circular.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

30 Oct 2020

Board Meeting

Shree Ganesh Biotech (India) Ltd - 539470 - Outcome Of The Board Meeting Held On Today …

BSE India

We hereby inform you that the Board of Directors of the Company at its meeting held today has: 1. Consider and Approved Un-Audited Financial Result for the Quarter and Half Year ended on 30th September 2020. 2. Resignation of Mr. Kalpak Mahendrabhai Vadodaria (DIN: 07664637) from the Directorship of the Company has been accepted with effect from 30.10.2020.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

30 Oct 2020

Result

Shree Ganesh Biotech (India) Ltd - 539470 - Financial Results For Quarter And Half Year Ended …

BSE India

pdf

Shree Ganesh Bio-Tech (India) Ltd.

27 Oct 2020

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Intimation for Intimation Regarding Postponement And …

BSE India

Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2020 ,inter alia, to consider and approve This has reference to our earlier announcement dated 21st October, 2020, regarding intimation of date of Board Meeting, which was scheduled to be held on Tuesday, 27th October, 2020, inter-alia, to consider and approve the Un audited Financial Results of the Company for the quarter and half year ended on 30th September, 2020. We hereby inform you that due to unavoidable circumstances, the said Meeting of the Board of Directors of the Company has been postponed to and rescheduled on Friday, 30th October, 2020. Please take the above intimation in your records and kindly acknowledge receipts.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

21 Oct 2020

Board Meeting

Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Intimation for Compliance Of Regulation 29 …

BSE India

Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2020 ,inter alia, to consider and approve Notice pursuant to regulation 29 of SEBI (LODR), Regulation, 2015, be and is hereby given that the meeting of the Board of Directors of the Company will be held on Tuesday, October 27, 2020, inter alia, to consider the Un-Audited financial results of the company for quarter and half year ended on September 30, 2020. Please take the above intimation in your records and kindly acknowledge receipts.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

20 Oct 2020

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Submission Of Certificate Under Regulation 40(9) Of SEBI …

BSE India

With reference to the above, please find enclosed herewith Certificate under Regulation 40(9) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 of the Company for the half year ended 30.09.2020 Please find above and acknowledge the same. Thanking You.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

16 Oct 2020

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Shareholding for the Period Ended September 30, 2020

BSE India

Shree Ganesh Biotech (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here

Shree Ganesh Bio-Tech (India) Ltd.

06 Oct 2020

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) …

BSE India

Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we herewith submit certificate from Satellite Corporate Services Private Limited, Registrar & Share Transfer Agent of the Company for the quarter ended 30th September 2020 This is for your information and records. Thanking You.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

06 Oct 2020

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Compliance Certificate Pursuant To Regulation 7(3) Of The …

BSE India

The Company has appointed SATELLITE CORPORATE SERVICES PVT LTD having Registration No.lNR000003639 as Registrar and Share Transfer Agent for handling share transfers and allied matters. Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure requirements) Regulation 2015, we do hereby confirm that for the half financial year ended on September 30, 2020, all the activities in relation to both physical and electronic share transfer facilities for the Company, are maintained by Satellite Corporate Services Pvt Limited (CIN - U65990MH1994PTC077057), having its Office at A-Wing Office No.106 and 107, Dattani Plaza, AndheriKurla Road, East West Indl Estate, Sakinaka, Mumbai - 400072.

pdf

Is Shree Ganesh Bio-Tech (India) Ltd. worth buying?

272 Votes:

Buy 73.53%

Sell 8.82%

Hold 17.65%